Where does Sevgi Gurkan work?

Sevgi Gurkan is Founder, Chief Executive Officer, and Member of the Board of Directors of Perfuse Therapeutics and SPARK Advisor at Stanford University.

What does Sevgi Gurkan invest in?

Sevgi Gurkan invests in Biotech.

What check size does Sevgi Gurkan write?

Sevgi Gurkan typically writes checks of $1M – $75M.

What companies did Sevgi Gurkan found?

Sevgi Gurkan founded Perfuse Therapeutics.

Where did Sevgi Gurkan go to school?

Sevgi Gurkan studied at Icahn School of Medicine at Mount Sinai (Master's degree, Clinical Research); Icahn School of Medicine at Mount Sinai (Nephrology, Translational research on mechanisms of graft tolerance); University of Southern California (Pediatrics).

Sevgi Gurkan

InvestorFounder

SPARK Advisor at Stanford University · Venture Partner at OrbiMed · Founder, Chief Executive Officer, and Member of the Board of Directors at Perfuse Therapeutics

San Francisco Bay Area

Writes $1M – $75M checks · typically $4M

FoundedPerfuse Therapeutics

Find your path to Sevgi

707 people in our graph can introduce you to Sevgi.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Charlotte Jones-Burton to introduce you to Sevgi

You →Charlotte · together at Robert Wood Johnson University Hospital (2013–2014) →Sevgi

Ask Jamie Chen to introduce you to Sevgi

You →Jamie · together at Corteria Pharmaceuticals →Sevgi

Ask Sam Okafor to introduce you to Sevgi

You →Sam · 5 people · together at OrbiMed →Sevgi

Your email: the people you already email who know Sevgi
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Sevgi
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Sevgi Gurkan joined OrbiMed in 2018 as a Venture Partner. She was previously a founding member of Merck Research Laboratories' South San Francisco Discovery site and a Director in Early Drug Development at MRL. Earlier in her career she was an Associate Professor at Rutgers, Director of the Pediatric Kidney Transplant Program at RWJ University Hospital, and a pediatric nephrologist; she holds a medical degree from Hacettepe University and a Master of Science in Clinical Research from Mount Sinai School of Medicine.

Invests in

Biotech

Founder, Chief Executive Officer, and Member of the Board of Directors at Perfuse Therapeutics

Intro paths

→

In turn, Sevgi can intro founders to Perfuse Therapeutics's investors below.

Perfuse Therapeutics's investors · 7

Access BiotechnologyNew York Catalio Capital Management, LPNew York HatterasRaleigh Hatteras Venture PartnersResearch Triangle · $500K – $4M checks LAVHong Kong · $5M – $15M checks Lilly Asia VenturesHong Kong · since 2020 OrbiMedNew York · $1M – $75M checks · since 2019

Experience

Stanford UniversitySPARK Advisorcurrent2025 — present
Corteria PharmaceuticalsMember Board of Directorscurrent2023 — present
Perfuse TherapeuticsFounder, President and CEOcurrent2018 — presentSan Francisco, California
OrbiMedVenture Partnercurrent2018 — presentSan Francisco Bay Area
MerckGroup Lead / Director / Discovery Biology South San Francisco2016 — 2018630 Gateway Blvd South San Francisco
MerckMedical Director / Early Clinical Development2014 — 2016Rahway
Rutgers UniversityAssociate Professor/Pediatric Nephrology2008 — 2016
Robert Wood Johnson University HospitalDirector, Pediatric Kidney Transplant Center2013 — 2014
Child Health Institute of New JerseyPhysician Scientist2010 — 2014New Brunswick, NJ

Skills & more

Board Level1Board Administration1Medical Education7Board Certified3Clinical Research15Medicine5Pediatrics6Medical Research2Clinical Trials8Research5Healthcare5Hospitals3

+8 more

ImmunologyTranslational ResearchTreatmentIn VitroIn VivoProtocolLaboratoryNephrology

Languages English · Spanish · Turkish

From Sevgi's professional profile.

Colleagues at Stanford University

Alan Ma

Campus Lead at The MBA Fund

Alex Gould

General Partner at The Valley Fund

Aman Verjee

General Partner at Practical Venture Capital

Amit Etkin

Founder at Alto Neuroscience

Amy Chang

Founder, Accompany at Decibel Partners

Anand Lalwani

Angel at Wispr AI

Andrew Ng

Managing General Partner at AI Fund

Anjney Midha

General Partner at Andreessen Horowitz

Frequently asked questions

Who is Sevgi Gurkan?: Sevgi Gurkan joined OrbiMed in 2018 as a Venture Partner. She was previously a founding member of Merck Research Laboratories' South San Francisco Discovery site and a Director in Early Drug Development at MRL. Earlier in her career she was an Associate Professor at Rutgers, Director of the Pediatric Kidney Transplant Program at RWJ University Hospital, and a pediatric nephrologist; she holds a medical degree from Hacettepe University and a Master of Science in Clinical Research from Mount Sinai School of Medicine.
Where does Sevgi Gurkan work?: Sevgi Gurkan is Founder, Chief Executive Officer, and Member of the Board of Directors of Perfuse Therapeutics and SPARK Advisor at Stanford University.
What does Sevgi Gurkan invest in?: Sevgi Gurkan invests in Biotech.
What check size does Sevgi Gurkan write?: Sevgi Gurkan typically writes checks of $1M – $75M.
What companies did Sevgi Gurkan found?: Sevgi Gurkan founded Perfuse Therapeutics.
Where did Sevgi Gurkan go to school?: Sevgi Gurkan studied at Icahn School of Medicine at Mount Sinai (Master's degree, Clinical Research); Icahn School of Medicine at Mount Sinai (Nephrology, Translational research on mechanisms of graft tolerance); University of Southern California (Pediatrics).